Federal IDR outcomes: General and other surgery in Oklahoma
In 2025 Q1–Q4, the provider or facility offer prevailed in 98.4% of 8,168 determined Federal IDR dispute line items for general and other surgery in Oklahoma. The median prevailing offer was 2.00x the QPA (25th–75th percentile 1.50x–2.58x; n = 7,941). The median time to a decision was 32 business days (n = 8,168).
Determined line items
8,168
2025 Q1–Q4 · 0 split decisions excluded
Provider win rate
98.4%
n = 8,168 · 2025 Q1–Q4
Median payment vs QPA
2.00x
middle half 1.50x–2.58x · n = 7,941 · 2025 Q1–Q4
Median days to decision
32
business days, from dispute initiation · n = 8,168 · 2025 Q1–Q4
Dollar amounts are not shown for specialty groups: the CMS QPA and Offers file, the only source of dollar figures, has no specialty field. See methodology.
By period
| Period | Line items | Win % | Median ×QPA | 25th–75th | Ratio n | Median days |
|---|---|---|---|---|---|---|
| 2025 Q1–Q4 | 8,168 | 98.4% | 2.00x | 1.50x–2.58x | 7,941 | 32 |
| 2024 Q1–Q4 | 1,751 | 95.0% | 2.00x | 1.42x–2.99x | 1,559 | 72 |
| 2023 Q1–Q4 | Fewer than 30 determined line items; not shown. | |||||
| 2023 Q1–2025 Q4 | 9,919 | 97.8% | 2.00x | 1.47x–2.67x | 9,500 | not pooled |
Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.
Most disputed CPT codes
| CPT code | Line items | Win % | Median ×QPA | Ratio n | Median days |
|---|---|---|---|---|---|
| 99285 Emergency department visit with high level of medical decision making | 434 | 94.9% | 2.04x | 430 | 30 |
| 85025 Complete blood cell count (red cells, white blood cell, platelets), automated te | 418 | 98.3% | 3.16x | 410 | 31.5 |
| 80053 Blood test, comprehensive group of blood chemicals | 394 | 98.5% | 1.14x | 388 | 32 |
| 96375 Injection of additional new drug or substance into vein | 190 | 99.5% | 1.71x | 180 | 31 |
| 96374 Injection of drug or substance into vein | 167 | 98.2% | 1.02x | 159 | 31 |
| 93005 Routine electrocardiogram (ECG) using at least 12 leads with tracing | 162 | 98.8% | 1.51x | 156 | 33.5 |
| 81001 Manual urinalysis test with examination using microscope, automated | 151 | 98.0% | 1.17x | 147 | 30 |
| 36415 Insertion of needle into vein for collection of blood sample | 147 | 100.0% | 2.12x | 145 | 33 |
| 84484 Troponin (protein) analysis, quantitative | 138 | 99.3% | 1.17x | 134 | 33 |
| 70450 CT scan head or brain without contrast | 135 | 99.3% | 2.64x | 135 | 29 |
| 71045 X-ray of chest, 1 view | 133 | 98.5% | 1.38x | 130 | 31 |
| 83690 Lipase (fat enzyme) level | 124 | 98.4% | 1.31x | 122 | 30 |
| 74177 CT scan of abdomen and pelvis with contrast | 121 | 97.5% | 2.23x | 120 | 31 |
| 99284 Emergency department visit with moderate level of medical decision making | 118 | 97.5% | 2.00x | 118 | 27 |
| 96361 Infusion into a vein for hydration, each additional hour | 116 | 100.0% | 1.38x | 111 | 34 |
| 96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 101 | 98.0% | 1.05x | 96 | 31 |
| 84703 Gonadotropin (reproductive hormone) analysis | 94 | 96.8% | 2.00x | 92 | 31 |
| 82962 Blood glucose (sugar) test performed by hand-held instrument | 93 | 98.9% | 5.65x | 89 | 32 |
| 83735 Magnesium level | 88 | 100.0% | 7.62x | 86 | 31.5 |
| 72125 CT scan of upper spine without contrast | 75 | 100.0% | 5.12x | 75 | 27 |
2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.
Related: all specialties in Oklahoma · General and other surgery in all states
FAQ
What is the Federal IDR provider win rate for general and other surgery in Oklahoma?
In 2025 Q1–Q4, the provider or facility offer was selected in 98.4% of 8,168 determined dispute line items for general and other surgery in Oklahoma. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.
How do Federal IDR payments compare with the QPA for general and other surgery in Oklahoma?
In 2025 Q1–Q4, the median prevailing offer was 2.00x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 1.50x to 2.58x (n = 7,941 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.
How long do Federal IDR decisions take for general and other surgery in Oklahoma?
In 2025 Q1–Q4, the median was 32 business days (n = 8,168 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).